Terms of availability for SMEs
Referring to the small size of our Company, strategic development could follow the next procedure:, Direct investigation in small & big labs in Europe, including commercialization, followed by an appropriate selection of local distributors technically accompanied by our structure.|Generate interest among major players in the in vitro diagnostic, with complementary products from our development or from our new technologies.|Initiate join venture collaboration with reliable partners with converging interests and complementary skills in order to enter new markets with a strategy similar to that applied in Europe.
Quality labels and accreditations
2003 CE registration for all products, 2005 certification for ISO 9001-2000, 2005 certification for ISO 13485, 2009 certification for ISO 9001-2008, 2008 member of the European BIO & Diagnostic Cluster BIOWIN and WallDX, 2009 foundation of nanoQ, LTD sister Company specialized in the synthesis and coating of metallic nanoparticles, 2010 implementation of the standard 15189 in the establishment of technical records, All reagents are liquid, stable and ready for use, All calibrators are immediately calibrated against international reference material as: IFCC, CRM 470, WHO, CDC....|Barcode available for specific analysers, Validated applications for all opened Biochemistry Analysers
